(2R,3aR,5R,6R,7E,9E,12R,16Z,17aR)-6-(((2R,5S,6R)-5-(Dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl)-oxy)-17-methoxy-5,12-dimethyl-2-((1-((2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methoxy)-3a,4,5,6,11,12,15,17a-octahydro-2H-furo[2,3-f][1]-oxacyclohexadecin-14(3H)-one

ID: ALA4578813

Chembl Id: CHEMBL4578813

PubChem CID: 155564965

Max Phase: Preclinical

Molecular Formula: C37H58N4O12

Molecular Weight: 750.89

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CO/C1=C\CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@@H]2C[C@H](OCc3cn([C@H]4O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]4O)nn3)O[C@@H]12

Standard InChI:  InChI=1S/C37H58N4O12/c1-21-16-24-17-32(48-20-25-18-41(39-38-25)37-35(46)34(45)33(44)29(19-42)52-37)53-36(24)28(47-6)13-14-30(43)49-22(2)10-8-7-9-11-27(21)51-31-15-12-26(40(4)5)23(3)50-31/h7-9,11,13,18,21-24,26-27,29,31-37,42,44-46H,10,12,14-17,19-20H2,1-6H3/b8-7+,11-9+,28-13-/t21-,22-,23-,24-,26+,27+,29+,31+,32-,33+,34-,35+,36-,37+/m1/s1

Standard InChI Key:  ABFAXLJYKPKRMA-ASWBBHMMSA-N

Alternative Forms

  1. Parent:

    ALA4578813

    ---

Associated Targets(non-human)

Bacillus spizizenii (1898 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 750.89Molecular Weight (Monoisotopic): 750.4051AlogP: 1.73#Rotatable Bonds: 9
Polar Surface Area: 196.55Molecular Species: BASEHBA: 16HBD: 4
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.33CX Basic pKa: 9.26CX LogP: 1.33CX LogD: -0.52
Aromatic Rings: 1Heavy Atoms: 53QED Weighted: 0.27Np Likeness Score: 1.36

References

1. Klich K, Pyta K, Kubicka MM, Ruszkowski P, Celewicz L, Gajecka M, Przybylski P..  (2016)  Synthesis, Antibacterial, and Anticancer Evaluation of Novel Spiramycin-Like Conjugates Containing C(5) Triazole Arm.,  59  (17): [PMID:27501415] [10.1021/acs.jmedchem.6b00764]

Source